BIOAVAILABILITY AND PHARMACOKINETICS IN MAN OF ACIPIMOX, A NEW ANTI-LIPOLYTIC AND HYPOLIPEMIC AGENT

被引：43
作者：
MUSATTI, L
MAGGI, E
MORO, E
VALZELLI, G
TAMASSIA, V
机构：
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1981年 / 9卷 / 05期
关键词：
D O I：
10.1177/030006058100900515
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：381 / 386
页数：6
相关论文
共 7 条
[1]  
AMBROGI V, 1980, EUR J MED CHEM, V15, P157
[2]  
FRAGIACOMO C, 1980, 7 INT S DRUG AFF LIP, P240
[3]   INHIBITION OF LIPOLYSIS BY NICOTINIC-ACID AND BY ACIPIMOX [J].
FUCCELLA, LM ;
GOLDANIGA, G ;
LOVISOLO, P ;
MAGGI, E ;
MUSATTI, L ;
MANDELLI, V ;
SIRTORI, CR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) :790-795
[4]   PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .1. MECHANISM OF ACTION [J].
LOVISOLO, PP ;
BRIATICOVANGOSA, G ;
ORSINI, G ;
RONCHI, R ;
ANGELUCCI, R ;
VALZELLI, G .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02) :151-161
[5]   PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .2. ANTI-LIPOLYTIC AND BLOOD LIPID LOWERING ACTIVITY [J].
LOVISOLO, PP ;
BRIATICOVANGOSA, G ;
ORSINI, G ;
RONCHI, R ;
ANGELUCCI, R .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02) :163-174
[6]   REDUCED TRIGLYCERIDEMIA AND INCREASED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AFTER TREATMENT WITH ACIPIMOX, A NEW INHIBITOR OF LIPOLYSIS [J].
SIRTORI, CR ;
GIANFRANCESCHI, G ;
SIRTORI, M ;
BERNINI, F ;
DESCOVICH, G ;
MONTAGUTI, U ;
FUCCELLA, LM ;
MUSATTI, L .
ATHEROSCLEROSIS, 1981, 38 (3-4) :267-271
[7]  
WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P136
1